A detailed history of Bowen Hanes & CO Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bowen Hanes & CO Inc holds 2,204 shares of MRK stock, worth $214,757. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,204
Previous 2,204 -0.0%
Holding current value
$214,757
Previous $272,000 8.09%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$113.24 - $131.95 $9,738 - $11,347
-86 Reduced 3.76%
2,204 $291,000
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $5,973 - $6,510
-55 Reduced 2.35%
2,290 $264,000
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $87,911 - $98,758
-1,040 Reduced 30.72%
2,345 $202,000
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $6,345 - $7,192
76 Added 2.3%
3,385 $308,000
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $2,867 - $3,153
-40 Reduced 1.19%
3,309 $249,000
Q2 2021

Aug 12, 2021

SELL
$70.31 - $77.77 $69,606 - $76,992
-990 Reduced 22.82%
3,349 $260,000
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $704 - $801
-10 Reduced 0.23%
4,339 $336,000
Q2 2019

Aug 13, 2019

SELL
$69.84 - $81.59 $209,520 - $244,770
-3,000 Reduced 40.82%
4,349 $365,000
Q1 2019

May 13, 2019

SELL
$69.58 - $79.36 $968,553 - $1.1 Million
-13,920 Reduced 65.45%
7,349 $611,000
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $1.1 Million - $1.28 Million
16,920 Added 389.05%
21,269 $1.63 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $3,049 - $3,583
60 Added 1.4%
4,349 $264,000
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $251,635 - $270,764
4,289
4,289 $275,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Bowen Hanes & CO Inc Portfolio

Follow Bowen Hanes & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowen Hanes & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bowen Hanes & CO Inc with notifications on news.